 | • レポートコード：MRC2102QY4023 • 出版社/出版日： / 2021年1月 • レポート形態：英文、PDF、146ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医療機器 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYリサーチ社の本調査レポートでは、世界の吸入薬用装置市場について種類別（ドライパウダー吸入器、定量吸入器、ネブライザー、ソフトミスト吸入器）、用途別（クリニック、病院、家庭）、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・吸入薬用装置市場の概要 ・世界の主要地域別吸入薬用装置市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の吸入薬用装置市場規模2015-2026：種類別（ドライパウダー吸入器、定量吸入器、ネブライザー、ソフトミスト吸入器） ・世界の吸入薬用装置市場規模2015-2026：用途別（クリニック、病院、家庭） ・吸入薬用装置の米国市場規模2015-2020 ・吸入薬用装置のヨーロッパ市場規模2015-2020 ・吸入薬用装置の中国市場規模2015-2020 ・吸入薬用装置の日本市場規模2015-2020 ・吸入薬用装置の東南アジア市場規模2015-2020 ・吸入薬用装置のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・吸入薬用装置の製造コスト分析 ・販売チャネル、流通業者、顧客 ・吸入薬用装置の市場動向・機会・課題 ・調査の結論 |
Market Analysis and Insights: Global Devices for Inhaled Medications Market
The global Devices for Inhaled Medications market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
Global Devices for Inhaled Medications Scope and Market Size
The global Devices for Inhaled Medications market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Devices for Inhaled Medications market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Devices for Inhaled Medications market is segmented into
Dry Powder Inhalers
Metered-Dose Inhalers
Nebulizers
Soft Mist Inhaler
Segment by Application, the Devices for Inhaled Medications market is segmented into
Clinic
Hospital
Home
The Devices for Inhaled Medications market is analysed and market size information is provided by regions (countries). Segment by Application, the Devices for Inhaled Medications market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Devices for Inhaled Medications Market Share Analysis
Devices for Inhaled Medications market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Devices for Inhaled Medications business, the date to enter into the Devices for Inhaled Medications market, Devices for Inhaled Medications product introduction, recent developments, etc.
The major vendors covered:
Consort Medical
Inhalexper
Cambridge Consultants
Hovione
Catalent, Inc
VertMarkets, Inc
Qualicaps
3M
Aerovance
AstraZeneca
Boehringer Ingelheim
Chiesi
Cipla
Civitas/Alkermes
GlaxoSmithKline
Hovione
Mannkind
Mantecorp
Meda
MicroDose Therapeutx
Novartis
1 Devices for Inhaled Medications Market Overview
1.1 Devices for Inhaled Medications Product Scope
1.2 Devices for Inhaled Medications Segment by Type
1.2.1 Global Devices for Inhaled Medications Sales by Type (2020-2026)
1.2.2 Dry Powder Inhalers
1.2.3 Metered-Dose Inhalers
1.2.4 Nebulizers
1.2.5 Soft Mist Inhaler
1.3 Devices for Inhaled Medications Segment by Application
1.3.1 Global Devices for Inhaled Medications Sales Comparison by Application (2020-2026)
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Home
1.4 Devices for Inhaled Medications Market Estimates and Forecasts (2015-2026)
1.4.1 Global Devices for Inhaled Medications Sales Growth Rate (2015-2026)
1.4.2 Global Devices for Inhaled Medications Revenue and Growth Rate (2015-2026)
1.4.3 Global Devices for Inhaled Medications Price Trends (2015-2026)
2 Devices for Inhaled Medications Estimate and Forecast by Region
2.1 Global Devices for Inhaled Medications Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Devices for Inhaled Medications Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Devices for Inhaled Medications Sales Market Share by Region (2015-2020)
2.2.2 Global Devices for Inhaled Medications Revenue Market Share by Region (2015-2020)
2.3 Global Devices for Inhaled Medications Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Devices for Inhaled Medications Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Devices for Inhaled Medications Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Devices for Inhaled Medications Estimates and Projections (2015-2026)
2.4.2 Europe Devices for Inhaled Medications Estimates and Projections (2015-2026)
2.4.3 China Devices for Inhaled Medications Estimates and Projections (2015-2026)
2.4.4 Japan Devices for Inhaled Medications Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Devices for Inhaled Medications Estimates and Projections (2015-2026)
2.4.6 India Devices for Inhaled Medications Estimates and Projections (2015-2026)
3 Global Devices for Inhaled Medications Competition Landscape by Players
3.1 Global Top Devices for Inhaled Medications Players by Sales (2015-2020)
3.2 Global Top Devices for Inhaled Medications Players by Revenue (2015-2020)
3.3 Global Devices for Inhaled Medications Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Devices for Inhaled Medications as of 2019)
3.4 Global Devices for Inhaled Medications Average Price by Company (2015-2020)
3.5 Manufacturers Devices for Inhaled Medications Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Devices for Inhaled Medications Players (Opinion Leaders)
4 Global Devices for Inhaled Medications Market Size by Type
4.1 Global Devices for Inhaled Medications Historic Market Review by Type (2015-2020)
4.1.1 Global Devices for Inhaled Medications Sales Market Share by Type (2015-2020)
4.1.2 Global Devices for Inhaled Medications Revenue Market Share by Type (2015-2020)
4.1.3 Global Devices for Inhaled Medications Price by Type (2015-2020)
4.2 Global Devices for Inhaled Medications Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Devices for Inhaled Medications Sales Forecast by Type (2021-2026)
4.2.2 Global Devices for Inhaled Medications Revenue Forecast by Type (2021-2026)
4.2.3 Global Devices for Inhaled Medications Price Forecast by Type (2021-2026)
5 Global Devices for Inhaled Medications Market Size by Application
5.1 Global Devices for Inhaled Medications Historic Market Review by Application (2015-2020)
5.1.1 Global Devices for Inhaled Medications Sales Market Share by Application (2015-2020)
5.1.2 Global Devices for Inhaled Medications Revenue Market Share by Application (2015-2020)
5.1.3 Global Devices for Inhaled Medications Price by Application (2015-2020)
5.2 Global Devices for Inhaled Medications Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Devices for Inhaled Medications Sales Forecast by Application (2021-2026)
5.2.2 Global Devices for Inhaled Medications Revenue Forecast by Application (2021-2026)
5.2.3 Global Devices for Inhaled Medications Price Forecast by Application (2021-2026)
6 United States Devices for Inhaled Medications Market Facts & Figures
6.1 United States Devices for Inhaled Medications Sales Market Share by Company (2015-2020)
6.2 United States Devices for Inhaled Medications Sales Market Share by Type (2015-2020)
6.3 United States Devices for Inhaled Medications Sales Market Share by Application (2015-2020)
7 Europe Devices for Inhaled Medications Market Facts & Figures
7.1 Europe Devices for Inhaled Medications Sales Market Share by Company (2015-2020)
7.2 Europe Devices for Inhaled Medications Sales Market Share by Type (2015-2020)
7.3 Europe Devices for Inhaled Medications Sales Market Share by Application (2015-2020)
8 China Devices for Inhaled Medications Market Facts & Figures
8.1 China Devices for Inhaled Medications Sales Market Share by Company (2015-2020)
8.2 China Devices for Inhaled Medications Sales Market Share by Type (2015-2020)
8.3 China Devices for Inhaled Medications Sales Market Share by Application (2015-2020)
9 Japan Devices for Inhaled Medications Market Facts & Figures
9.1 Japan Devices for Inhaled Medications Sales Market Share by Company (3015-3030)
9.2 Japan Devices for Inhaled Medications Sales Market Share by Type (2015-2020)
9.3 Japan Devices for Inhaled Medications Sales Market Share by Application (2015-2020)
10 Southeast Asia Devices for Inhaled Medications Market Facts & Figures
10.1 Southeast Asia Devices for Inhaled Medications Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Devices for Inhaled Medications Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Devices for Inhaled Medications Sales Market Share by Application (2015-2020)
11 India Devices for Inhaled Medications Market Facts & Figures
11.1 India Devices for Inhaled Medications Sales Market Share by Company (2015-2020)
11.2 India Devices for Inhaled Medications Sales Market Share by Type (2015-2020)
11.3 India Devices for Inhaled Medications Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Devices for Inhaled Medications Business
12.1 Consort Medical
12.1.1 Consort Medical Corporation Information
12.1.2 Consort Medical Business Overview
12.1.3 Consort Medical Devices for Inhaled Medications Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Consort Medical Devices for Inhaled Medications Products Offered
12.1.5 Consort Medical Recent Development
12.2 Inhalexper
12.2.1 Inhalexper Corporation Information
12.2.2 Inhalexper Business Overview
12.2.3 Inhalexper Devices for Inhaled Medications Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Inhalexper Devices for Inhaled Medications Products Offered
12.2.5 Inhalexper Recent Development
12.3 Cambridge Consultants
12.3.1 Cambridge Consultants Corporation Information
12.3.2 Cambridge Consultants Business Overview
12.3.3 Cambridge Consultants Devices for Inhaled Medications Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Cambridge Consultants Devices for Inhaled Medications Products Offered
12.3.5 Cambridge Consultants Recent Development
12.4 Hovione
12.4.1 Hovione Corporation Information
12.4.2 Hovione Business Overview
12.4.3 Hovione Devices for Inhaled Medications Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Hovione Devices for Inhaled Medications Products Offered
12.4.5 Hovione Recent Development
12.5 Catalent, Inc
12.5.1 Catalent, Inc Corporation Information
12.5.2 Catalent, Inc Business Overview
12.5.3 Catalent, Inc Devices for Inhaled Medications Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Catalent, Inc Devices for Inhaled Medications Products Offered
12.5.5 Catalent, Inc Recent Development
12.6 VertMarkets, Inc
12.6.1 VertMarkets, Inc Corporation Information
12.6.2 VertMarkets, Inc Business Overview
12.6.3 VertMarkets, Inc Devices for Inhaled Medications Sales, Revenue and Gross Margin (2015-2020)
12.6.4 VertMarkets, Inc Devices for Inhaled Medications Products Offered
12.6.5 VertMarkets, Inc Recent Development
12.7 Qualicaps
12.7.1 Qualicaps Corporation Information
12.7.2 Qualicaps Business Overview
12.7.3 Qualicaps Devices for Inhaled Medications Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Qualicaps Devices for Inhaled Medications Products Offered
12.7.5 Qualicaps Recent Development
12.8 3M
12.8.1 3M Corporation Information
12.8.2 3M Business Overview
12.8.3 3M Devices for Inhaled Medications Sales, Revenue and Gross Margin (2015-2020)
12.8.4 3M Devices for Inhaled Medications Products Offered
12.8.5 3M Recent Development
12.9 Aerovance
12.9.1 Aerovance Corporation Information
12.9.2 Aerovance Business Overview
12.9.3 Aerovance Devices for Inhaled Medications Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Aerovance Devices for Inhaled Medications Products Offered
12.9.5 Aerovance Recent Development
12.10 AstraZeneca
12.10.1 AstraZeneca Corporation Information
12.10.2 AstraZeneca Business Overview
12.10.3 AstraZeneca Devices for Inhaled Medications Sales, Revenue and Gross Margin (2015-2020)
12.10.4 AstraZeneca Devices for Inhaled Medications Products Offered
12.10.5 AstraZeneca Recent Development
12.11 Boehringer Ingelheim
12.11.1 Boehringer Ingelheim Corporation Information
12.11.2 Boehringer Ingelheim Business Overview
12.11.3 Boehringer Ingelheim Devices for Inhaled Medications Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Boehringer Ingelheim Devices for Inhaled Medications Products Offered
12.11.5 Boehringer Ingelheim Recent Development
12.12 Chiesi
12.12.1 Chiesi Corporation Information
12.12.2 Chiesi Business Overview
12.12.3 Chiesi Devices for Inhaled Medications Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Chiesi Devices for Inhaled Medications Products Offered
12.12.5 Chiesi Recent Development
12.13 Cipla
12.13.1 Cipla Corporation Information
12.13.2 Cipla Business Overview
12.13.3 Cipla Devices for Inhaled Medications Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Cipla Devices for Inhaled Medications Products Offered
12.13.5 Cipla Recent Development
12.14 Civitas/Alkermes
12.14.1 Civitas/Alkermes Corporation Information
12.14.2 Civitas/Alkermes Business Overview
12.14.3 Civitas/Alkermes Devices for Inhaled Medications Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Civitas/Alkermes Devices for Inhaled Medications Products Offered
12.14.5 Civitas/Alkermes Recent Development
12.15 GlaxoSmithKline
12.15.1 GlaxoSmithKline Corporation Information
12.15.2 GlaxoSmithKline Business Overview
12.15.3 GlaxoSmithKline Devices for Inhaled Medications Sales, Revenue and Gross Margin (2015-2020)
12.15.4 GlaxoSmithKline Devices for Inhaled Medications Products Offered
12.15.5 GlaxoSmithKline Recent Development
12.16 Hovione
12.16.1 Hovione Corporation Information
12.16.2 Hovione Business Overview
12.16.3 Hovione Devices for Inhaled Medications Sales, Revenue and Gross Margin (2015-2020)
12.16.4 Hovione Devices for Inhaled Medications Products Offered
12.16.5 Hovione Recent Development
12.17 Mannkind
12.17.1 Mannkind Corporation Information
12.17.2 Mannkind Business Overview
12.17.3 Mannkind Devices for Inhaled Medications Sales, Revenue and Gross Margin (2015-2020)
12.17.4 Mannkind Devices for Inhaled Medications Products Offered
12.17.5 Mannkind Recent Development
12.18 Mantecorp
12.18.1 Mantecorp Corporation Information
12.18.2 Mantecorp Business Overview
12.18.3 Mantecorp Devices for Inhaled Medications Sales, Revenue and Gross Margin (2015-2020)
12.18.4 Mantecorp Devices for Inhaled Medications Products Offered
12.18.5 Mantecorp Recent Development
12.19 Meda
12.19.1 Meda Corporation Information
12.19.2 Meda Business Overview
12.19.3 Meda Devices for Inhaled Medications Sales, Revenue and Gross Margin (2015-2020)
12.19.4 Meda Devices for Inhaled Medications Products Offered
12.19.5 Meda Recent Development
12.20 MicroDose Therapeutx
12.20.1 MicroDose Therapeutx Corporation Information
12.20.2 MicroDose Therapeutx Business Overview
12.20.3 MicroDose Therapeutx Devices for Inhaled Medications Sales, Revenue and Gross Margin (2015-2020)
12.20.4 MicroDose Therapeutx Devices for Inhaled Medications Products Offered
12.20.5 MicroDose Therapeutx Recent Development
12.21 Novartis
12.21.1 Novartis Corporation Information
12.21.2 Novartis Business Overview
12.21.3 Novartis Devices for Inhaled Medications Sales, Revenue and Gross Margin (2015-2020)
12.21.4 Novartis Devices for Inhaled Medications Products Offered
12.21.5 Novartis Recent Development
13 Devices for Inhaled Medications Manufacturing Cost Analysis
13.1 Devices for Inhaled Medications Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Devices for Inhaled Medications
13.4 Devices for Inhaled Medications Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Devices for Inhaled Medications Distributors List
14.3 Devices for Inhaled Medications Customers
15 Market Dynamics
15.1 Devices for Inhaled Medications Market Trends
15.2 Devices for Inhaled Medications Opportunities and Drivers
15.3 Devices for Inhaled Medications Market Challenges
15.4 Devices for Inhaled Medications Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Devices for Inhaled Medications Sales (K Units) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Devices for Inhaled Medications Sales (K Units) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Devices for Inhaled Medications Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Devices for Inhaled Medications Sales (K Units) by Region (2015-2020)
Table 5. Global Devices for Inhaled Medications Sales Market Share by Region (2015-2020)
Table 6. Global Devices for Inhaled Medications Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Devices for Inhaled Medications Revenue Share by Region (2015-2020)
Table 8. Global Devices for Inhaled Medications Sales (K Units) Forecast by Region (2021-2026)
Table 9. Global Devices for Inhaled Medications Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Devices for Inhaled Medications Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Devices for Inhaled Medications Revenue Share Forecast by Region (2021-2026)
Table 12. Global Devices for Inhaled Medications (K Units) of Key Companies (2015-2020)
Table 13. Global Devices for Inhaled Medications Sales Share by Company (2015-2020)
Table 14. Global Devices for Inhaled Medications Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Devices for Inhaled Medications Revenue Share by Company (2015-2020)
Table 16. Global Devices for Inhaled Medications by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Devices for Inhaled Medications as of 2019)
Table 17. Global Devices for Inhaled Medications Average Price (USD/Unit) of Key Company (2015-2020)
Table 18. Manufacturers Devices for Inhaled Medications Manufacturing Sites and Area Served
Table 19. Manufacturers Devices for Inhaled Medications Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Devices for Inhaled Medications Players
Table 22. Global Devices for Inhaled Medications Sales (K Units) by Type (2015-2020)
Table 23. Global Devices for Inhaled Medications Sales Share by Type (2015-2020)
Table 24. Global Devices for Inhaled Medications Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Devices for Inhaled Medications Price (K Units) by Type (2015-2020)
Table 26. Global Devices for Inhaled Medications Sales Share by Type (2021-2026)
Table 27. Global Devices for Inhaled Medications Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Devices for Inhaled Medications Revenue Share by Type (2021-2026)
Table 29. Global Devices for Inhaled Medications Price (K Units) by Type (2021-2026)
Table 30. Global Devices for Inhaled Medications Sales (K Units) by Application (2015-2020)
Table 31. Global Devices for Inhaled Medications Sales Share by Application (2015-2020)
Table 32. Global Devices for Inhaled Medications Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Devices for Inhaled Medications Price (K Units) by Application (2015-2020)
Table 34. Global Devices for Inhaled Medications Sales (K Units) by Application (2021-2026)
Table 35. Global Devices for Inhaled Medications Sales Share by Application (2021-2026)
Table 36. Global Devices for Inhaled Medications Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Devices for Inhaled Medications Revenue Share by Application (2021-2026)
Table 38. Global Devices for Inhaled Medications Price (K Units) by Application (2021-2026)
Table 39. United States Devices for Inhaled Medications Sales (K Units) by Company (2015-2020)
Table 40. United States Devices for Inhaled Medications Sales Market Share by Company (2015-2020)
Table 41. United States Devices for Inhaled Medications Sales (K Units) by Type (2015-2020)
Table 42. United States Devices for Inhaled Medications Sales Market Share by Type (2015-2020)
Table 43. United States Devices for Inhaled Medications Sales (K Units) by Application (2015-2020)
Table 44. United States Devices for Inhaled Medications Sales Market Share by Application (2015-2020)
Table 45. Europe Devices for Inhaled Medications Sales (K Units) by Company (2015-2020)
Table 46. Europe Devices for Inhaled Medications Sales Market Share by Company (2015-2020)
Table 47. Europe Devices for Inhaled Medications Sales (K Units) by Type (2015-2020)
Table 48. Europe Devices for Inhaled Medications Sales Market Share by Type (2015-2020)
Table 49. Europe Devices for Inhaled Medications Sales (K Units) by Application (2015-2020)
Table 50. Europe Devices for Inhaled Medications Sales Market Share by Type (2015-2020)
Table 51. China Devices for Inhaled Medications Sales (K Units) by Company (2015-2020)
Table 52. China Devices for Inhaled Medications Sales Market Share by Company (2015-2020)
Table 53. China Devices for Inhaled Medications Sales (K Units) by Type (2015-2020)
Table 54. China Devices for Inhaled Medications Sales Market Share by Type (2015-2020)
Table 55. China Devices for Inhaled Medications Sales (K Units) by Application (2015-2020)
Table 56. China Devices for Inhaled Medications Sales Market Share by Application (2015-2020)
Table 57. Japan Devices for Inhaled Medications Sales (K Units) by Company (2015-2020)
Table 58. Japan Devices for Inhaled Medications Sales Market Share by Company (2015-2020)
Table 59. Japan Devices for Inhaled Medications Sales (K Units) by Type (2015-2020)
Table 60. Japan Devices for Inhaled Medications Sales Market Share by Type (2015-2020)
Table 61. Japan Devices for Inhaled Medications Sales (K Units) by Application (2015-2020)
Table 62. Japan Devices for Inhaled Medications Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Devices for Inhaled Medications Sales (K Units) by Company (2015-2020)
Table 64. Southeast Asia Devices for Inhaled Medications Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Devices for Inhaled Medications Sales (K Units) by Type (2015-2020)
Table 66. Southeast Asia Devices for Inhaled Medications Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Devices for Inhaled Medications Sales (K Units) by Type (2015-2020)
Table 68. Southeast Asia Devices for Inhaled Medications Sales Market Share by Application (2015-2020)
Table 69. India Devices for Inhaled Medications Sales (K Units) by Company (2015-2020)
Table 70. India Devices for Inhaled Medications Sales Market Share by Company (2015-2020)
Table 71. India Devices for Inhaled Medications Sales (K Units) by Type (2015-2020)
Table 72. India Devices for Inhaled Medications Sales Market Share by Type (2015-2020)
Table 73. India Devices for Inhaled Medications Sales (K Units) by Application (2015-2020)
Table 74. India Devices for Inhaled Medications Sales Market Share by Application (2015-2020)
Table 75. Consort Medical Corporation Information
Table 76. Consort Medical Description and Business Overview
Table 77. Consort Medical Devices for Inhaled Medications Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. Consort Medical Devices for Inhaled Medications Product
Table 79. Consort Medical Recent Development
Table 80. Inhalexper Corporation Information
Table 81. Inhalexper Description and Business Overview
Table 82. Inhalexper Devices for Inhaled Medications Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Inhalexper Devices for Inhaled Medications Product
Table 84. Inhalexper Recent Development
Table 85. Cambridge Consultants Corporation Information
Table 86. Cambridge Consultants Description and Business Overview
Table 87. Cambridge Consultants Devices for Inhaled Medications Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Cambridge Consultants Devices for Inhaled Medications Product
Table 89. Cambridge Consultants Recent Development
Table 90. Hovione Corporation Information
Table 91. Hovione Description and Business Overview
Table 92. Hovione Devices for Inhaled Medications Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Hovione Devices for Inhaled Medications Product
Table 94. Hovione Recent Development
Table 95. Catalent, Inc Corporation Information
Table 96. Catalent, Inc Description and Business Overview
Table 97. Catalent, Inc Devices for Inhaled Medications Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Catalent, Inc Devices for Inhaled Medications Product
Table 99. Catalent, Inc Recent Development
Table 100. VertMarkets, Inc Corporation Information
Table 101. VertMarkets, Inc Description and Business Overview
Table 102. VertMarkets, Inc Devices for Inhaled Medications Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. VertMarkets, Inc Devices for Inhaled Medications Product
Table 104. VertMarkets, Inc Recent Development
Table 105. Qualicaps Corporation Information
Table 106. Qualicaps Description and Business Overview
Table 107. Qualicaps Devices for Inhaled Medications Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Qualicaps Devices for Inhaled Medications Product
Table 109. Qualicaps Recent Development
Table 110. 3M Corporation Information
Table 111. 3M Devices for Inhaled Medications Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. 3M Description and Business Overview
Table 113. 3M Devices for Inhaled Medications Product
Table 114. 3M Recent Development
Table 115. Aerovance Corporation Information
Table 116. Aerovance Devices for Inhaled Medications Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Aerovance Description and Business Overview
Table 118. Aerovance Devices for Inhaled Medications Product
Table 119. Aerovance Recent Development
Table 120. AstraZeneca Corporation Information
Table 121. AstraZeneca Description and Business Overview
Table 122. AstraZeneca Devices for Inhaled Medications Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 123. AstraZeneca Devices for Inhaled Medications Product
Table 124. AstraZeneca Recent Development
Table 125. Boehringer Ingelheim Corporation Information
Table 126. Boehringer Ingelheim Description and Business Overview
Table 127. Boehringer Ingelheim Devices for Inhaled Medications Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 128. Boehringer Ingelheim Devices for Inhaled Medications Product
Table 129. Boehringer Ingelheim Recent Development
Table 130. Chiesi Corporation Information
Table 131. Chiesi Description and Business Overview
Table 132. Chiesi Devices for Inhaled Medications Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 133. Chiesi Devices for Inhaled Medications Product
Table 134. Chiesi Recent Development
Table 135. Cipla Corporation Information
Table 136. Cipla Description and Business Overview
Table 137. Cipla Devices for Inhaled Medications Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 138. Cipla Devices for Inhaled Medications Product
Table 139. Cipla Recent Development
Table 140. Civitas/Alkermes Corporation Information
Table 141. Civitas/Alkermes Description and Business Overview
Table 142. Civitas/Alkermes Devices for Inhaled Medications Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 143. Civitas/Alkermes Devices for Inhaled Medications Product
Table 144. Civitas/Alkermes Recent Development
Table 145. GlaxoSmithKline Corporation Information
Table 146. GlaxoSmithKline Description and Business Overview
Table 147. GlaxoSmithKline Devices for Inhaled Medications Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 148. GlaxoSmithKline Devices for Inhaled Medications Product
Table 149. GlaxoSmithKline Recent Development
Table 150. Hovione Corporation Information
Table 151. Hovione Description and Business Overview
Table 152. Hovione Devices for Inhaled Medications Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 153. Hovione Devices for Inhaled Medications Product
Table 154. Hovione Recent Development
Table 155. Mannkind Corporation Information
Table 156. Mannkind Description and Business Overview
Table 157. Mannkind Devices for Inhaled Medications Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 158. Mannkind Devices for Inhaled Medications Product
Table 159. Mannkind Recent Development
Table 160. Mantecorp Corporation Information
Table 161. Mantecorp Description and Business Overview
Table 162. Mantecorp Devices for Inhaled Medications Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 163. Mantecorp Devices for Inhaled Medications Product
Table 164. Mantecorp Recent Development
Table 165. Meda Corporation Information
Table 166. Meda Description and Business Overview
Table 167. Meda Devices for Inhaled Medications Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 168. Meda Devices for Inhaled Medications Product
Table 169. Meda Recent Development
Table 170. MicroDose Therapeutx Corporation Information
Table 171. MicroDose Therapeutx Description and Business Overview
Table 172. MicroDose Therapeutx Devices for Inhaled Medications Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 173. MicroDose Therapeutx Devices for Inhaled Medications Product
Table 174. MicroDose Therapeutx Recent Development
Table 175. Novartis Corporation Information
Table 176. Novartis Description and Business Overview
Table 177. Novartis Devices for Inhaled Medications Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 178. Novartis Devices for Inhaled Medications Product
Table 179. Novartis Recent Development
Table 180. Production Base and Market Concentration Rate of Raw Material
Table 181. Key Suppliers of Raw Materials
Table 182. Devices for Inhaled Medications Distributors List
Table 183. Devices for Inhaled Medications Customers List
Table 184. Devices for Inhaled Medications Market Key Trends
Table 185. Devices for Inhaled Medications Key Opportunities and Drivers
Table 186. Devices for Inhaled Medications Market Challenges
Table 187. Research Programs/Design for This Report
Table 188. Key Data Information from Secondary Sources
Table 189. Key Data Information from Primary Sources
List of Figures
Figure 1. Devices for Inhaled Medications Product Picture
Figure 2. Global Devices for Inhaled Medications Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Devices for Inhaled Medications Market Share by Application in 2020 & 2026
Figure 6. Clinic Examples
Figure 7. Hospital Examples
Figure 8. Home Examples
Figure 9. Global Devices for Inhaled Medications Sales (K Units) Growth Rate (2015-2026)
Figure 10. Global Devices for Inhaled Medications Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Devices for Inhaled Medications Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 12. Global Devices for Inhaled Medications Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Devices for Inhaled Medications Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Devices for Inhaled Medications Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Devices for Inhaled Medications Sales (K Units) Growth Rate (2015-2026)
Figure 16. Europe Devices for Inhaled Medications Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Devices for Inhaled Medications Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Devices for Inhaled Medications Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Devices for Inhaled Medications Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Devices for Inhaled Medications Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Devices for Inhaled Medications Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Devices for Inhaled Medications Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Devices for Inhaled Medications Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Devices for Inhaled Medications Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Devices for Inhaled Medications Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Devices for Inhaled Medications Players Market Share by Revenue in Devices for Inhaled Medications 2015 & 2019
Figure 27. Devices for Inhaled Medications Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Devices for Inhaled Medications Revenue Share by Type (2015-2020)
Figure 29. Global Devices for Inhaled Medications Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Devices for Inhaled Medications Revenue Share by Application (2015-2020)
Figure 31. Global Devices for Inhaled Medications Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Devices for Inhaled Medications Sales Market Share by Type in 2019
Figure 33. United States Devices for Inhaled Medications Sales Market Share by Type in 2019
Figure 34. Europe Devices for Inhaled Medications Sales Market Share by Company in 2019
Figure 35. Europe Devices for Inhaled Medications Sales Market Share by Type in 2019
Figure 36. Europe Devices for Inhaled Medications Sales Market Share by Application in 2019
Figure 37. China Devices for Inhaled Medications Sales Market Share by Company in 2019
Figure 38. China Devices for Inhaled Medications Sales Market Share by Type in 2019
Figure 39. China Devices for Inhaled Medications Sales Market Share by Application in 2019
Figure 40. Japan Devices for Inhaled Medications Sales Market Share by Company in 2019
Figure 41. Japan Devices for Inhaled Medications Sales Market Share by Type in 2019
Figure 42. Japan Devices for Inhaled Medications Sales Market Share by Application in 2019
Figure 43. Southeast Asia Devices for Inhaled Medications Sales Market Share by Company in 2019
Figure 44. Southeast Asia Devices for Inhaled Medications Sales Market Share by Type in 2019
Figure 45. Southeast Asia Devices for Inhaled Medications Sales Market Share by Application in 2019
Figure 46. India Devices for Inhaled Medications Sales Market Share by Company in 2019
Figure 47. India Devices for Inhaled Medications Sales Market Share by Type in 2019
Figure 48. India Devices for Inhaled Medications Sales Market Share by Application in 2019
Figure 49. Key Raw Materials Price Trend
Figure 50. Manufacturing Cost Structure of Devices for Inhaled Medications
Figure 51. Manufacturing Process Analysis of Devices for Inhaled Medications
Figure 52. Devices for Inhaled Medications Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Porter's Five Forces Analysis
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
定量吸入器の世界市場レポート2020 Market Analysis and Insights: Global Metered Dose Inhalers Market The global Metered Dose Inhalers market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Metered Dose Inhalers Scope and Market Size The global Metered Dose Inha…- 小線源治療装置の世界市場レポート2020 Brachytherapy is referred to as sealed source radiation therapy because the radiation source is sealed and placed inside or near the body part requiring radiation therapy. Besides the treatment of most body part tumors, brachytherapy is commonly used to treat the cancers of the cervix, breast, skin,…
- 乳房組織生検装置の世界市場レポート2020 Breast Biopsy is a procedure in which a sample of a suspicious breast growth is removed and examined, usually for the presence of cancer. The sample is suctioned out through a needle or removed surgically. A breast biopsy is the best way to evaluate if a suspicious lump or portion of your breast is …
- ポータブルナビゲーションデバイスの世界市場レポート2020 Market Analysis and Insights: Global Portable Navigation Devices Market The global Portable Navigation Devices market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Portable Navigation Devices Scope and Market Size The global…
- 尿流動態装置の世界市場レポート2020 Urodynamic investigations help a physician to diagnose the cause and identify the nature or any dysfunction of lower urinary tract. The principle objective of the urodynamic test is to understand the problems/disorders in the lower urinary tract by duplicating the symptoms. It also determines the ca…